Phase
Condition
Carcinoma
Treatment
Carevive software
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of histologically confirmed renal cell carcinoma of any subtype witheither pathological or radiographic evidence of metastatic disease
Greater than 18 years of age
A participating Wilmot Cancer Center oncologist has determined that candidate shouldbe started on either oral targeted therapy or immunotherapy for treatment of theiradvanced RCC; this can be for first-line or any subsequent line therapy
Able to provide written informed consent
Proficient in the English language and self-reports as literate
Must have an active email address or access to a smart device on which text messagescan be received
Exclusion
Exclusion Criteria:
Women cannot be breast-feeding
Does not have regular access to the internet
Unable to come to the Wilmot Cancer Center for appointments every 3-4 months forroutine visits with their primary oncologist
Subjects who were on the study previously will not be allowed to re-enroll in theevent of a treatment change
Study Design
Connect with a study center
University of Rochester - Wilmot Cancer Institute
Rochester, New York 14642
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.